News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
99,177 Results
Type
Article (7126)
Company Profile (40)
Press Release (92007)
Multimedia
Podcasts (17)
Webinars (2)
Section
Business (27866)
Career Advice (128)
Deals (4282)
Drug Delivery (40)
Drug Development (14230)
Employer Resources (12)
FDA (3005)
Job Trends (2144)
News (49922)
Policy (6101)
Tag
2027 Pharm Country Standard (2)
Academia (433)
Accelerated approval (15)
Adcomms (7)
Allergies (46)
Alliances (9065)
ALS (35)
Alzheimer's disease (344)
Antibody-drug conjugate (ADC) (115)
Approvals (2978)
Artificial intelligence (125)
Autoimmune disease (54)
Automation (9)
Bankruptcy (19)
Best Places to Work (1811)
BIOSECURE Act (17)
Biosimilars (141)
Biotechnology (29)
Bladder cancer (42)
Brain cancer (14)
Breast cancer (129)
Cancer (1006)
Cardiovascular disease (51)
Career advice (116)
Career pathing (5)
CAR-T (50)
CDC (9)
Cell therapy (172)
Cervical cancer (8)
Clinical research (12396)
Collaboration (455)
Compensation (98)
Complete response letters (24)
COVID-19 (594)
CRISPR (12)
C-suite (165)
Cystic fibrosis (17)
Data (1401)
Denatured (6)
Depression (15)
Diabetes (72)
Diagnostics (634)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (89)
Drug pricing (42)
Drug shortages (1)
Duchenne muscular dystrophy (77)
Earnings (10185)
Editorial (16)
Employer branding (3)
Employer resources (10)
Events (13158)
Executive appointments (170)
FDA (3810)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (296)
Gene editing (45)
Generative AI (18)
Gene therapy (183)
GLP-1 (150)
Government (1400)
Grass and pollen (1)
Guidances (81)
Healthcare (1990)
HIV (11)
Huntington's disease (14)
IgA nephropathy (20)
Immunology and inflammation (95)
Immuno-oncology (24)
Indications (24)
Infectious disease (662)
Inflammatory bowel disease (67)
Inflation Reduction Act (7)
Influenza (33)
Intellectual property (37)
Interviews (11)
IPO (2140)
IRA (16)
Job creations (388)
Job search strategy (108)
JPM (9)
Kidney cancer (3)
Labor market (8)
Layoffs (68)
Leadership (3)
Legal (564)
Liver cancer (13)
Longevity (9)
Lung cancer (154)
Lymphoma (72)
Machine learning (14)
Management (2)
Manufacturing (303)
MASH (30)
Medical device (1234)
Medtech (1246)
Mergers & acquisitions (2352)
Metabolic disorders (184)
Multiple sclerosis (42)
NASH (2)
Neurodegenerative disease (71)
Neuropsychiatric disorders (8)
Neuroscience (573)
NextGen: Class of 2026 (700)
Non-profit (358)
Now hiring (15)
Obesity (70)
Opinion (66)
Ovarian cancer (40)
Pain (23)
Pancreatic cancer (32)
Parkinson's disease (45)
Partnered (10)
Patents (71)
Patient recruitment (84)
Peanut (25)
People (8316)
Pharmaceutical (9)
Pharmacy benefit managers (7)
Phase 1 (4075)
Phase 2 (5146)
Phase 3 (4538)
Pipeline (1313)
Policy (120)
Postmarket research (298)
Preclinical (1600)
Press Release (66)
Prostate cancer (39)
Psychedelics (6)
Radiopharmaceuticals (42)
Rare diseases (198)
Real estate (931)
Recruiting (4)
Regulatory (5448)
Reports (11)
Research institute (397)
Resumes & cover letters (11)
Rett syndrome (5)
RNA editing (3)
RSV (17)
Schizophrenia (28)
Series A (52)
Series B (30)
Service/supplier (3)
Sickle cell disease (20)
Special edition (5)
Spinal muscular atrophy (23)
Sponsored (14)
Startups (590)
State (1)
Stomach cancer (5)
Supply chain (16)
Tariffs (21)
The Weekly (11)
Vaccines (294)
Venture capital (15)
Weight loss (29)
Women's health (7)
Date
Today (13)
Last 7 days (110)
Last 30 days (471)
Last 365 days (6137)
2026 (674)
2025 (6128)
2024 (6640)
2023 (7092)
2022 (9215)
2021 (9768)
2020 (8446)
2019 (5942)
2018 (4540)
2017 (5111)
2016 (4653)
2015 (5295)
2014 (3733)
2013 (2895)
2012 (2984)
2011 (3146)
2010 (2572)
Location
Africa (99)
Alabama (18)
Alaska (1)
Arizona (18)
Arkansas (2)
Asia (8101)
Australia (940)
California (2243)
Canada (436)
China (384)
Colorado (50)
Connecticut (60)
Delaware (101)
Europe (14686)
Florida (318)
Georgia (40)
Hawaii (1)
Idaho (14)
Illinois (95)
India (34)
Indiana (57)
Iowa (10)
Japan (99)
Kansas (11)
Kentucky (13)
Louisiana (2)
Maine (5)
Maryland (449)
Massachusetts (1634)
Michigan (32)
Minnesota (77)
Mississippi (4)
Missouri (23)
Montana (5)
Nebraska (1)
Nevada (12)
New Hampshire (5)
New Jersey (752)
New Mexico (4)
New York (578)
North Carolina (304)
North Dakota (9)
Northern California (1072)
Ohio (64)
Oklahoma (11)
Oregon (5)
Pennsylvania (329)
Puerto Rico (2)
Rhode Island (6)
South America (140)
South Carolina (3)
Southern California (938)
Tennessee (9)
Texas (331)
United States (7664)
Utah (43)
Virginia (27)
Washington D.C. (9)
Washington State (179)
West Virginia (1)
Wisconsin (15)
99,177 Results for "hcw biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease
November 19, 2025
·
9 min read
Press Releases
HCW Biologics to Participate in the 2025 Maxim Growth Summit
October 17, 2025
·
4 min read
Press Releases
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results
November 17, 2025
·
14 min read
Press Releases
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
November 20, 2025
·
6 min read
Press Releases
HCW Biologics’ Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer
October 17, 2025
·
4 min read
Press Releases
HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer
November 10, 2025
·
6 min read
Press Releases
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
November 10, 2025
·
5 min read
Press Releases
HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results
August 18, 2025
·
14 min read
Press Releases
HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements
June 26, 2025
·
2 min read
Press Releases
HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization
May 14, 2025
·
6 min read
1 of 9,918
Next
